3,3'-diindolylmethane clinical trials
Also written diindolylmethane.
How each study uses 3,3'-diindolylmethane is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
8 studies that test it; most in 2007 (2)
| Year | Studies |
|---|---|
| 2000 | 1 |
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2009 | 1 |
| 2011 | 1 |
| 2019 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 0 · Other 8
National Cancer Institute (NCI) (2) · Queen Mary University of London (1) · University of Arizona (1) · New York Presbyterian Hospital (1) · Boston University (1) · The New York Eye & Ear Infirmary (1) · Women's College Hospital (1)
Often tested with
Tested in the same studies.
Lauric acid (1) · Perilla seed oil (1)
Studies
Open first, then newest update. How each study uses 3,3'-diindolylmethane is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 8
- The Effect of Food Supplements on Food Intake and Gut Hormone LevelsCompletedNot applicableQueen Mary University of LondonNCT04292236Written as Lauric Acid, Perilla Oil and Diindolylmethane
- Diindolylmethane in Treating Patients With Breast CancerCompletedNot applicableUniversity of ArizonaNCT01391689Written as diindolylmethane
- New Therapy of Laryngeal Papilloma In ChildrenTerminatedNot applicableBoston UniversityNCT00591305Written as diindolylmethane (DIM)
- Oral Diindolylmethane (DIM) for the Treatment of Cervical DysplasiaCompletedPhase 3New York Presbyterian HospitalNCT00212381Written as di indolylmethane (DIM)
- Diindolylmethane in Preventing Cancer in Healthy VolunteersCompletedPhase 1National Cancer Institute (NCI)NCT00784394Written as diindolylmethane
- Diindolylmethane in Treating Patients Undergoing Surgery for Stage I or Stage II Prostate CancerCompletedPhase 1National Cancer Institute (NCI)NCT00450229Written as diindolylmethane
- DIM as a Treatment for Thyroid DiseaseTerminatedEarly Phase 1The New York Eye & Ear InfirmaryNCT01846364Written as Diindolylmethane (DIM)
- The Potential for Oral Diindolylmethane (DIM) Supplementation to Increase the Production of the BRCA1 Protein in BRCA1 Mutation CarriersStatus unknownPhase 1Women's College HospitalNCT01022333Written as Diindolylmethane (DIM)
Codes
What other systems call 3,3'-diindolylmethane · ClinicalTrials.gg INT002648
- MeSH (NLM) C0163923,3'-diindolylmethaneConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) SSZ9HQT61Z3,3'-DIINDOLYLMETHANEConfirmed FDA, NLM, Wikidata
- RxNorm 1603521Confirmed FDA, Wikidata
- Wikidata Q46340533,3'-diindolylmethaneConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C53434DiindolylmethaneOne source FDA
- DrugBank DB11875One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C016392 | 3,3'-diindolylmethane | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | SSZ9HQT61Z | 3,3'-DIINDOLYLMETHANE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 1603521 | — | Confirmed FDA, Wikidata |
| Wikidata | Q4634053 | 3,3'-diindolylmethane | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C53434 | Diindolylmethane | One source FDA |
| DrugBank | DB11875 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.